GenPMTO Evaluation
Launched by THE BEHAVIOURAL INSIGHTS TEAM · Oct 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The GenPMTO Evaluation is a clinical trial that is studying a parenting program called Generation Parent Management Training - Oregon Model (GenPMTO). This program is designed to help caregivers learn positive parenting techniques through interactive methods like group discussions, role-playing, and watching videos. The goal is to improve parenting skills and positively impact children and young people, particularly those aged 8-14, by helping them do better in school, reducing behavioral issues, and preventing involvement in crime.
Caregivers who spend the most time with a child or young person in this age range and live in specific areas can participate in the study, especially if the child has faced challenges like poor school attendance, bullying, or criminal behavior. Participants can expect to join group sessions where they will learn and practice new parenting strategies over a 10-14 week period. It's important to note that certain conditions, such as recent participation in another parenting program or serious mental health concerns, may prevent someone from joining the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Caregivers are eligible to participate in the feasibility study (including receiving GenPMTO) if they:
- • Have a child or young person (CYP) between the ages of 8-14.
- • Are the primary caregiver (i.e. spend the most time with the CYP and are available to care for them).
- • Live within one of the boroughs in which GenPMTO is being delivered (during the feasibility study).
- And, if one of or more of the following is present:
- • CYPs have engaged in criminal behaviour, such as breaking the law or "offending behaviour" - for both non-violent and violent crimes.
- • CYPs have engaged in violent and challenging behaviour (including within the home, e.g. against parents and/or siblings).
- • CYPs have been reported as bullying other individual(s) in or outside of school settings.
- • CYPs have low attendance at school (\<50% within the last academic year).
- • CYPs have been excluded from school within the last academic year.
- • CYPs are engaged in substance abuse/misuse (e.g. drugs, alcohol)
- • CYPs are at risk of involvement by gangs.
- • CYPs are at risk of exploitation, or negative influence, by criminal peers.
- • CYPs have a sibling(s) that has entered into the criminal justice system.
- Exclusion Criteria - Caregivers will be excluded from the feasibility study it at least any of the following are present:
- • Caregiver(s) have received a parenting programme in the last two months, or are currently receiving one.
- • Caregiver(s) and CYP does not have working proficiency in English, such that participation in GenPMTO and research activities would be unfeasible.
- • Family has plans to move out of the borough within the 10-14 week delivery timeline, and thus may not be available for full delivery of GenPMTO during the feasibility study phase.
- • Severe developmental delay for caregiver or CYP which may prevent caregiver from attending GenPMTO delivery sessions, implementing GenPMTO parenting strategies, or participating in evaluation.
- • Caregiver(s) and/or CYPs are actively homicidal, suicidal or psychotic.
- • Problem sexual behaviour is the central behavioural concern for child/young person.
- • Significant child protection concern (i.e. basic needs of children are not being met by caregivers.
About The Behavioural Insights Team
The Behavioural Insights Team (BIT) is a pioneering organization dedicated to applying behavioral science to improve public policy and services. Founded in the UK, BIT leverages insights from psychology, economics, and neuroscience to design and implement interventions that promote positive behavior change across various sectors, including health, education, and social welfare. Through rigorous research and evaluation, BIT collaborates with governments and organizations globally to enhance the effectiveness of programs and policies, ultimately aiming to improve outcomes for individuals and communities. Their commitment to evidence-based practices positions them as a leader in harnessing behavioral insights for impactful clinical trials and public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
London, , United Kingdom
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported